It gives me great pleasure to present you with the first issue of the Mount Sinai Diabetes Center Newsletter. The mission of the Mount Sinai Diabetes Center is to provide the highest quality care to our patients, to improve the outcomes of patients with diabetes, to be at the forefront of cutting edge research in diabetes, to train future leaders and innovators in the field of diabetes and to serve our community through outreach programs and patient advocacy. As you will see in this newsletter, we are achieving success on all fronts. Our clinical program continues to grow and the number of patients we serve is increasing every year. Our recent research breakthroughs in areas such as beta cell regeneration, brain control of metabolism, and an artificial pancreas are leading the way to improving care and hopefully finding cures for diabetes, both type 1 and type 2. We have providers that provide outreach to our community with education, free seminars, and we continue to advocate for more government programs to stem the diabetes epidemic, such as our recently published op-ed advocating for a sugar tax. I hope you enjoy learning about our activities as you read this newsletter. We welcome any comments, suggestions, or questions.
Lillian and Henry M. Stratton Professor of Molecular Medicine
Chief, Division of Endocrinology, Diabetes and Bone Disease
Icahn School of Medicine at Mount Sinai
